FLSM
GRCL

Frazier Life Sciences Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Frazier Life Sciences Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,890,102
Closed -$9.31M – 46
2022
Q3 		$9.31M Sell
2,890,102
-221,449
-7% -$713K 0.72% 30
2022
Q2 		$17.1M Sell
3,111,551
-334,422
-10% -$1.84M 1.62% 17
2022
Q1 		$8.03M Buy
+3,445,973
New +$8.03M 0.68% 32